Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1373847

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1373847

Global Osteoarthritis Treatment Market Size, Share, Growth Analysis, By Type(Medication, Physical Therapy and Surgical Procedures), By Application(Knee Osteoarthritis, Hip Osteoarthritis) - Industry Forecast 2023-2030

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Osteoarthritis Treatment Market size was valued at USD 7.4 billion in 2021 and is poised to grow from USD 8.03 billion in 2022 to USD 15.42 billion by 2030, growing at a CAGR of 8.5% during the forecast period (2023-2030).

The global osteoarthritis treatment market has witnessed significant growth in recent years, driven by the rising prevalence of osteoarthritis, an aging population, and the increasing demand for effective treatment options. With advancements in healthcare and improved life expectancy, the proportion of elderly individuals susceptible to osteoarthritis has risen significantly. As a result, there is a growing need for innovative and efficient treatment options to manage the symptoms and improve the quality of life for these patients. Moreover, the rising awareness about the available treatment options and the importance of early intervention has further propelled the market growth. Healthcare providers and organizations are actively engaged in educating patients about osteoarthritis, its risk factors, and the various treatment modalities available. This increased awareness has led to early diagnosis and timely treatment initiation, driving the demand for osteoarthritis treatment products.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Osteoarthritis Treatment Market Segmental Analysis

Global Osteoarthritis Treatment Market is segmented by type, application, and region. Based on type, the market can be segmented into Medications, Physical Therapy and Surgical Procedures. Based on application, the market is segmented into Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Spine Osteoarthritis, Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Osteoarthritis Treatment Market Dynamics

Drivers of the Global Osteoarthritis Treatment Market

Rising Obesity Rates

The escalating global rates of obesity contribute significantly to the increased occurrence of osteoarthritis. As obesity continues to rise worldwide, there is a growing prevalence of osteoarthritis cases. This surge in cases drives the demand for treatment options as obese individuals often require comprehensive approaches to manage their condition effectively.

Restraints in the Global Osteoarthritis Treatment Market

Lack of Disease-Modifying Therapies

The absence of disease-modifying therapies remains a significant challenge in the field of osteoarthritis treatment. Despite notable advancements, there is still a lack of effective therapies capable of slowing down or reversing the progression of osteoarthritis. This limitation impedes the overall management of the disease and negatively impacts treatment outcomes for patients.

Market Trends of the Global Osteoarthritis Treatment Key

A key market trend in the global Osteoarthritis Treatment market is the growing emphasis on personalized and multimodal approaches to manage the condition. Osteoarthritis is a degenerative joint disease that affects a significant portion of the global population, particularly the elderly. Traditionally, treatment approaches have focused on pain management and symptom relief through nonsteroidal anti-inflammatory drugs (NSAIDs) and analgesics. However, there is an increasing recognition that a one-size-fits-all approach may not be effective for all patients.

Product Code: SQMIG35A2305

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
    • Regulatory Landscape
    • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Osteoarthritis Treatment Market by Type
    • Market Overview
    • Medication
    • Physical Therapy and Surgical Procedures
  • Global Osteoarthritis Treatment Market by Application
    • Market Overview
    • Knee Osteoarthritis
    • Hip Osteoarthritis
    • Hand Osteoarthritis
    • Spine Osteoarthritis
    • Shoulder Osteoarthritis and Foot and Ankle Osteoarthritis
  • Global Osteoarthritis Treatment Market Size by Region
    • Market Overview
    • North America
  • USA
  • Canada
    • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
    • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
    • Latin America
  • Brazil
  • Rest of Latin America
    • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
  • By Development
  • By Company
  • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Johnson & Johnson Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Novartis International AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • AbbVie Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Eli Lilly and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bristol Myers Squibb Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Boehringer Ingelheim International GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Flexion Therapeutics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Bioventus LLC (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Zimmer Biomet Holdings, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Stryker Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
    • DJO Global, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!